We don’t know for sure that Donald Trump was the 79-year-old obese man who got special access to a weight-loss drug after a secret application from someone at the NIH. But the signs point strongly in his direction. If he is the one, the signs also suggest his health is much worse than what he and the White House want us to know.
In case you missed it, Stat recently reported that drug-maker Eli Lilly and Trump’s FDA allowed just one 79-year-man to get the drug, retatrutide, in April. The 80-year-old Trump was 79 in April. After the story was published, White House spokesperson Kush Desai wrote on Xitter, “this application was not for the President.” Which is not a denial that the drug was for Trump.
“It’s not clear why the patient couldn’t enroll in Lilly’s ongoing clinical trials of the drug,” Stat noted. “In interviews, 18 bioethics experts, obesity clinicians, and current and former government health officials told STAT that the application struck them as unusual. One after another, they questioned why Lilly would offer compassionate use — also known as expanded access — for a single patient when obesity is such a widespread condition.”
read more